Artículos por temáticas

Nuclear podosomes regulates cellular migration in Tau and Alzheimer's disease

Qureshi T, Chandrashekar M, Ananthanarayana V, Kumarappan M, Rangappa N, Velmurugan G, Chinnathambi S.

Adv Protein Chem Struct Biol. 2025;143:411-426. doi: 10.1016/bs.apcsb.2024.09.009. Epub 2024 Oct 2.

Methylated cell-free DNA as a novel biomarker in Alzheimer's disease

Zhen M, Dang M, Cao Z, Xia X, Peng F, Wang S, Liu Y.

Clin Chim Acta. 2025 Jan 30;566:120069. doi: 10.1016/j.cca.2024.120069. Epub 2024 Nov 30.

Rlip76 in ageing and Alzheimer's disease: Focus on oxidative stress and mitochondrial mechanisms

Bandaru M, Sultana OF, Islam MA, Rainier A, Reddy PH.

Ageing Res Rev. 2025 Jan;103:102600. doi: 10.1016/j.arr.2024.102600. Epub 2024 Nov 30.

TREM2 bridges microglia and extracellular microenvironment: Mechanistic landscape and therapeutical prospects on Alzheimer's disease

Zhao Y, Guo Q, Tian J, Liu W, Wang X.

Ageing Res Rev. 2025 Jan;103:102596. doi: 10.1016/j.arr.2024.102596. Epub 2024 Nov 27.

The immunomodulatory effects of psychedelics in Alzheimer's disease-related dementia

Mohammad Hosseini A, Khaleghzadeh-Ahangar H, Rahimi A.

Neuroscience. 2025 Jan 9;564:271-280. doi: 10.1016/j.neuroscience.2024.11.062. Epub 2024 Nov 26.

Investigating interleukin-8 in Alzheimer's disease: A comprehensive review

Righi D, Manco C, Pardini M, Stufano A, Schino V, Pelagotti V, Massa F, Stefano N, Plantone D.

J Alzheimers Dis. 2025 Jan;103(1):38-55. doi: 10.1177/13872877241298973. Epub 2024 Nov 18.

Heavy metals exposure and Alzheimer's disease: Underlying mechanisms and advancing therapeutic approaches

Althobaiti NA.

Behav Brain Res. 2025 Jan 5;476:115212. doi: 10.1016/j.bbr.2024.115212. Epub 2024 Aug 24.

An Expanded Narrative Review of Neurotransmitters on Alzheimer's Disease: The Role of Therapeutic Interventions on Neurotransmission

Akyuz E, Arulsamy A, Aslan FS, Sarisözen B, Guney B, Hekimoglu A, Yilmaz BN, Retinasamy T, Shaikh MF.

Mol Neurobiol. 2025 Feb;62(2):1631-1674. doi: 10.1007/s12035-024-04333-y. Epub 2024 Jul 16.

Ketone body metabolism and the NLRP3 inflammasome in Alzheimer's disease

Shippy DC, Evered AH, Ulland TK.

Immunol Rev. 2025 Jan;329(1):e13365. doi: 10.1111/imr.13365. Epub 2024 Jul 11.

The Link Between Matrix Metalloproteinases and Alzheimer's Disease Pathophysiology

Radosinska D, Radosinska J.

Mol Neurobiol. 2025 Jan;62(1):885-899. doi: 10.1007/s12035-024-04315-0. Epub 2024 Jun 27.

Fyn Kinase in Alzheimer's Disease: Unraveling Molecular Mechanisms and Therapeutic Implications

Meur S, Karati D.

Mol Neurobiol. 2025 Jan;62(1):643-660. doi: 10.1007/s12035-024-04286-2. Epub 2024 Jun 18.

Alzheimer's disease: insights into pathology, molecular mechanisms, and therapy

Zheng Q, Wang X.

Protein Cell. 2025 Feb 1;16(2):83-120. doi: 10.1093/procel/pwae026.

Alzheimer Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for Monitoring of Amyloid-Related Imaging Abnormalities

Cogswell PM, Andrews TJ, Barakos JA, Barkhof F, Bash S, Benayoun MD, Chiang GC, Franceschi AM, Jack CR Jr, Pillai JJ, Poussaint TY, Raji CA, Ramanan VK, Tanabe J, Tanenbaum L, Whitlow CT, Yu FF, Zahar

AJNR Am J Neuroradiol. 2025 Jan 8;46(1):24-32. doi: 10.3174/ajnr.A8469.

Brain interleukins and Alzheimer's disease

Abdelhamed HG, Hassan AA, Sakraan AA, Al-Deeb RT, Mousa DM, Aboul Ezz HS, Noor NA, Khadrawy YA, Radwan NM.

Metab Brain Dis. 2025 Feb 1;40(2):116. doi: 10.1007/s11011-025-01538-5.

APOE4, Alzheimer's and periodontal disease: A scoping review

Arévalo-Caro C, Arce Retana M, Losada Amaya S, Arboleda H, Gallart-Palau X, Serra A.

Ageing Res Rev. 2025 Mar;105:102649. doi: 10.1016/j.arr.2024.102649. Epub 2025 Jan 24.